Lotus Pharmaceutical Co., Ltd. Logo

Lotus Pharmaceutical Co., Ltd. (1795)

TWSE

Currency in TWD
195.50
+1.50 (+0.77%)

Closed

Aug 26, 2026

Day's Range

193.00
198.50

52 wk Range

170.50
369.50

Overview - 1795 - Lotus Pharmaceutical Co., Ltd.

Key Statistics

Valuation

Enterprise Value

104.30B

P/E (Trailing)

‪13.48‬

P/E (Forward)

‪7.69‬

PEG Ratio

‪-0.22‬

Price / Sales (TTM)

‪1.78‬

Price / Book

‪2.12‬

EV / EBITDA

‪11.33‬

Profitability

Gross Margin

‪50.73%‬

Profit Margin

‪13.22%‬

Operating Margin

‪26.48%‬

Return on Assets

‪6.20%‬

Return on Equity

‪16.86%‬

Ownership

Shares Outstanding

262.80M

Float

135.42M

Held by Insiders

‪48.60%‬

Held by Institutions

‪10.68%‬

Price stats

Beta

‪0.64‬

50-Day Avg

‪190.93‬

200-Day Avg

‪244.05‬

Dividends

Payout Ratio

‪40.15%‬

Analyst Consensus

Buy

4 analysts

Market Cap - 1795 - Lotus Pharmaceutical Co., Ltd.

Peers - 1795 - Lotus Pharmaceutical Co., Ltd.

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on TWSE.

Profile Summary - 1795 - Lotus Pharmaceutical Co., Ltd.

About

Lotus Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the development, manufacture, and sale of a wide range of healthcare products. Its primary function is to produce generic and specialty pharmaceuticals that cater to the healthcare needs across various therapeutic areas. Lotus Pharmaceutical focuses…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees0
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.